Key result
Genetic insights into glucose homeostasis and T2DM reveal key metabolic pathways and potential therapeutic targets.
Understanding the genetic basis of glucose homeostasis may provide insight into novel metabolic pathways and identify potential therapeutic targets for type 2 diabetes and metabolic syndrome.
This review summarizes the current understanding of the genetic basis of glucose homeostasis through genome-wide association scans and candidate gene studies of case-control and family-based designs. We highlight the implications of phenotype-direct (euglycemic clamp or frequently sampled intravenous glucose tolerance test) and indirect (fasting insulin and fasting glucose) measures on the determinants of insulin resistance and β-cell response that precede and contribute to the development of type 2 diabetes mellitus (T2DM) and the metabolic syndrome. Finally, we examine future approaches that may aid in understanding the biology of insulin resistance and T2DM. Over the past 2 decades, the prevalence of insulin resistance, the metabolic syndrome, and T2DM has increased. Ethnic differences in T2DM and insulin resistance are evident, with nonwhite populations having the greatest risk. There continue to be significant gaps in our knowledge regarding the metabolic, behavioral, and genetic determinants of these conditions. Understanding the genetic basis of glucose homeostasis, insulin resistance, and T2DM should provide insight on known and novel metabolic pathways that identify potential therapeutic targets and mechanisms for intervention.
No takes yet. Share an insight, caveat, or question.
Norris et al. (2012) conducted a review in Type 2 diabetes mellitus and metabolic syndrome. Understanding the genetic basis of glucose homeostasis, insulin resistance, and type 2 diabetes mellitus provides insight into metabolic pathways and potential therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: